Remember, Merck already let this asset go once and knows exactly what they gave up now. With FDA clarity now in hand, the strategic risk just dropped again. If you're Merck, you don't let this sit long enough for other suitors to show up and turn it into a bidding war.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Remember, Merck already let this asset go once and knows exactly what they gave up now. With FDA clarity now in hand, the strategic risk just dropped again. If you're Merck, you don't let this sit long enough for other suitors to show up and turn it into a bidding war.